Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis

Digestive Diseases and Sciences

Volumn 59, Issue 7, 2014, Pages 1594-1602

  Cuthbert, Jennifer A ^a,b   Arslanlar, Sami ^a,b   Yepuri, Jay ^a,b   Montrose, Marc ^c   Ahn, Chul W ^d   Shah, Jessica P ^a,b  

^a PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Texas State Department of Health Statistics   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alcoholic hepatitis scores; Discriminant function; Internal sensitivity index; Model of End stage Liver Disease; Prothrombin time

Indexed keywords

ALKALINE PHOSPHATASE; AMMONIA; BILIRUBIN; CREATININE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ALKALINE PHOSPHATASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISCRIMINANT ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; ICD-9; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE; LIVER FUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HEPATITIS, ALCOHOLIC; HOSPITALIZATION; HUMANS; MIDDLE AGED; PROGNOSIS; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84903517609     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-3020-3     Document Type: Article

References (22)

1. Maddrey WC. Alcoholic hepatitis: pathogenesis and approaches to treatment. Scand J Gastroenterol Suppl. 1990;175:118-130. (Pubitemid 20276635)
2. Mathurin P, Duchatelle V, Ramond MJ, et al Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology. 1996;110:1847-1853. (Pubitemid 26169222)
3. Mathurin P, Louvet A, Dharancy S. Treatment of severe forms of alcoholic hepatitis: where are we going? J Gastroenterol Hepatol. 2008;23:S60-S62. (Pubitemid 351389032)
4. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut. 1995;37:113-118.
5. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2022-2036. (Pubitemid 29076847)
6. Mathurin P. Corticosteroids for alcoholic hepatitis-what's next? J Hepatol. 2005;43:526-533.
7. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: glucocorticosteroids for alcoholic hepatitis-a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167-1178. (Pubitemid 351697274)
8. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology. 2010;51:307-328.
9. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193-199. (Pubitemid 8372264)
10. Carithers RL Jr, Herlong HF, Diehl AM, et al Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 1989;110:685-690. (Pubitemid 19121221)
11. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392-1394. (Pubitemid 26399036)
12. Tripodi A, Poller L, van den Besselaar AM, Mannucci PM. A proposed scheme for calibration of international reference preparations of thromboplastin for the prothrombin time. On behalf of the Subcommittee on Control of Anticoagulation. Thromb Haemost. 1995;74:1368-1369.
13. Poller L, Keown M, Chauhan N, et al European concerted action on anticoagulation. Evaluation of a method for International Sensitivity Index calibration of two point-of-care prothrombin time (PT) monitoring systems (CoaguChek Mini and TAS PTNC) with fresh plasmas based on whole-blood equivalent PT. Clin Chem . 2002;48:1672-1680.
14. Forrest EH, Evans CD, Stewart S, et al Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174-1179. (Pubitemid 41025916)
15. Dominguez M, Rincon D, Abraldes JG, et al A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008;103:2747-2756.
16. Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol . 2011;46:1127-1132.
17. Palaniyappan N, Subramanian V, Ramappa V, Ryder SD, Kaye P, Aithal GP. The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway? Int J Hepatol. 2012;2012:624675.
18. Lafferty H, Stanley AJ, Forrest EH. The management of alcoholic hepatitis: a prospective comparison of scoring systems. Aliment Pharmacol Ther . 2013;38:603-610.
19. Altamirano J, Higuera-de la Tijera F, Duarte-Rojo A et al The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis. Am J Gastroenterol . 2011;106:1472-1480.
20. UNOS. MELD/PELD calculator documentation. http://www.unos.org/docs/MELD- PELD-Calculator-Documentation.pdf. 2009.
21. Mathurin P, O'Grady J, Carithers RL, et al Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut . 2011;60: 255-260.
22. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology . 2000;119:1637-1648. (Pubitemid 32198689)